These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 25748808)
1. [A case of akin moyamoya disease associated with type-I diabetes mellitus managed by extracranial-intracranial bypass]. Akamatsu Y; Fujimura M; Sakata H; Endo H; Itabashi R; Tominaga T No Shinkei Geka; 2015 Mar; 43(3):227-33. PubMed ID: 25748808 [TBL] [Abstract][Full Text] [Related]
2. Local Vasogenic Edema without Cerebral Hyperperfusion after Direct Revascularization Surgery for Moyamoya Disease. Sakata H; Fujimura M; Mugikura S; Sato K; Tominaga T J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):e179-84. PubMed ID: 25957910 [TBL] [Abstract][Full Text] [Related]
3. Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability. Fujimura M; Shimizu H; Mugikura S; Tominaga T Surg Neurol; 2009 Feb; 71(2):223-7; discussion 227. PubMed ID: 18291489 [TBL] [Abstract][Full Text] [Related]
4. Disappearance of aneurysms associated with moyamoya disease after STA-MCA anastomosis with encephaloduro myosynangiosis. Ni W; Xu F; Xu B; Liao Y; Gu Y; Song D J Clin Neurosci; 2012 Mar; 19(3):485-7. PubMed ID: 22281383 [TBL] [Abstract][Full Text] [Related]
5. Treatment of Moyamoya Disease and Unruptured Intracranial Aneurysm in Floating-Harbor Syndrome. Coughlin DJ; Miller CA; Schuette AJ World Neurosurg; 2017 Aug; 104():1049.e1-1049.e6. PubMed ID: 28549641 [TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis. Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765 [TBL] [Abstract][Full Text] [Related]
7. Moyamoya disease associated with Behcet's disease. Joo SP; Kim TS; Lee JH; Lee JK; Kim JH; Kim SH; Kim MK; Cho KH J Clin Neurosci; 2006 Apr; 13(3):364-7. PubMed ID: 16581493 [TBL] [Abstract][Full Text] [Related]
8. Patients with moyamoya disease presenting with movement disorder. Pandey P; Bell-Stephens T; Steinberg GK J Neurosurg Pediatr; 2010 Dec; 6(6):559-66. PubMed ID: 21121731 [TBL] [Abstract][Full Text] [Related]
9. [Recurrent hyperperfusion after revascularization surgery for adult moyamoya disease: a case report]. Hayashi T; Kashiwazaki D; Akioka N; Kuwayama N; Kuroda S No Shinkei Geka; 2014 Jul; 42(7):621-7. PubMed ID: 25006102 [TBL] [Abstract][Full Text] [Related]
10. Relative contributions of the middle meningeal artery and superficial temporal artery in revascularization surgery for moyamoya syndrome in children: the results of superselective angiography. King JA; Armstrong D; Vachhrajani S; Dirks PB J Neurosurg Pediatr; 2010 Feb; 5(2):184-9. PubMed ID: 20121368 [TBL] [Abstract][Full Text] [Related]
11. Experience of treatment of moyamoya disease at the Clinic of Neurosurgery of Kaunas University of Medicine. Marcinkevicius E; Liutkus D; Gvazdaitis A Medicina (Kaunas); 2006; 42(2):130-6. PubMed ID: 16528129 [TBL] [Abstract][Full Text] [Related]
12. [Neovascularization after encephalo-duro-arterio-synangiosis in elderly quasi-moyamoya disease: a case report]. Kaga A; Nakano T; Hori S; Kamida T; Isono M; Kasai N No Shinkei Geka; 1997 Sep; 25(9):803-7. PubMed ID: 9300448 [TBL] [Abstract][Full Text] [Related]
13. Temporal profile of de novo development of moyamoya vasculopathy in an adult: case report. Shimoda Y; Fujimura M; Inoue T; Shimizu H; Tominaga T Neurol Med Chir (Tokyo); 2012; 52(5):339-42. PubMed ID: 22688072 [TBL] [Abstract][Full Text] [Related]
14. [Comparison of one-stage direct revascularization and medicine therapy for treatment of ischemic moyamoya disease]. Zhao H; You C Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Sep; 23(9):1097-100. PubMed ID: 19817297 [TBL] [Abstract][Full Text] [Related]
15. [Emergency Bypass Surgery for Progressive Cerebral Infarction Following Hemorrhagic Onset of Moyamoya Disease:A Case Report]. Hatakeyama J; Yanagisawa T; Kudo E; Togashi S; Shimizu H No Shinkei Geka; 2016 Oct; 44(10):843-849. PubMed ID: 27729604 [TBL] [Abstract][Full Text] [Related]
16. Adult-onset moyamoya disease with repetitive ischemic attacks successfully treated by superficial temporal-middle cerebral artery bypass--case report. Oya S; Tsutsumi K; Ueki K Neurol Med Chir (Tokyo); 2003 Mar; 43(3):138-41. PubMed ID: 12699122 [TBL] [Abstract][Full Text] [Related]
17. Flow-augmentation bypass for moyamoya disease. Fujimura M; Tominaga T J Neurosurg Sci; 2021 Jun; 65(3):277-286. PubMed ID: 33245218 [TBL] [Abstract][Full Text] [Related]
18. Pediatric moyamoya disease presenting with intracerebral hemorrhage--report of three cases and review of the literature. Suyama K; Yoshida K; Takahata H; Toda K; Baba H; Ishikawa Y; Hirose M; Nagata I Clin Neurol Neurosurg; 2008 Mar; 110(3):270-5. PubMed ID: 18035479 [TBL] [Abstract][Full Text] [Related]
19. [Pial synangiosis for moyamoya disease. The Bordeaux experience]. Jecko V; Penchet G; Champeaux C Neurochirurgie; 2016 Aug; 62(4):190-6. PubMed ID: 27113323 [TBL] [Abstract][Full Text] [Related]
20. Management of moyamoya syndrome in patients with Noonan syndrome. Gupta M; Choudhri OA; Feroze AH; Do HM; Grant GA; Steinberg GK J Clin Neurosci; 2016 Jun; 28():107-11. PubMed ID: 26778511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]